Chelsea Therapeutics International - Ownership and Business Overview

Life ScienceCompany

Chelsea Therapeutics International Ownership

Who owns Chelsea Therapeutics International?

Chelsea Therapeutics International is owned by H. Lundbeck A/S. It was acquired on June 24, 2014.

Chelsea Therapeutics International Business Overview

Where is Chelsea Therapeutics International headquartered?

Chelsea Therapeutics International is headquartered in Charlotte, North Carolina.

How many employees does Chelsea Therapeutics International have?

Chelsea Therapeutics International has 19 employees.

What sector is Chelsea Therapeutics International in?

Chelsea Therapeutics International is a life science company.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Chelsea Therapeutics International Ltd.

3530 Toringdon Way, Suite 200,
Charlotte, North Carolina 28277
United States,
(704) 341-1516
www.chelseatherapeutics.com

Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.